Amgen, Inc. (AMGN)
374.75
-0.75
(-0.20%)
USD |
NASDAQ |
Feb 20, 16:00
375.49
+0.74
(+0.20%)
After-Hours: 20:00
Amgen Total Liabilities (Quarterly) : 81.93B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 36.40B |
| Johnson & Johnson | 117.67B |
| Eli Lilly & Co. | 85.94B |
| Merck & Co., Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 90.59B |
| Shareholders Equity (Quarterly) | 8.658B |
| Debt to Equity Ratio | 6.403 |
| Current Ratio | 1.14 |
| Net Debt Paydown Yield | 0.56% |